2021
TCT-34 Hemoglobin Drop in the Absence of Overt Bleeding After Percutaneous Coronary Intervention is Associated With In-Hospital Mortality
Nikolakopoulos I, Vemmou E, Karacsonyi J, Garcia S, Henry T, Goessl M, Sharkey S, Burke M, Sorajja P, Traverse J, Wang Y, Mooney M, Poulose A, Chavez I, Simsek B, Kostantinis S, Rangan B, Brilakis E. TCT-34 Hemoglobin Drop in the Absence of Overt Bleeding After Percutaneous Coronary Intervention is Associated With In-Hospital Mortality. Journal Of The American College Of Cardiology 2021, 78: b13-b14. DOI: 10.1016/j.jacc.2021.09.884.Peer-Reviewed Original Research
2020
Coronary Intravascular Brachytherapy for Recurrent Coronary Drug-Eluting Stent In-Stent Restenosis: A Systematic Review and Meta-Analysis
Megaly M, Glogoza M, Xenogiannis I, Vemmou E, Nikolakopoulos I, Omer M, Saad M, Willson L, Monyak DJ, Sullivan P, Pershad A, Chavez I, Mooney M, Traverse J, Wang Y, Garcia S, Poulose A, Burke MN, Brilakis ES. Coronary Intravascular Brachytherapy for Recurrent Coronary Drug-Eluting Stent In-Stent Restenosis: A Systematic Review and Meta-Analysis. Cardiovascular Revascularization Medicine 2020, 23: 28-35. PMID: 32883584, DOI: 10.1016/j.carrev.2020.08.035.Peer-Reviewed Original ResearchConceptsTarget vessel revascularizationIncidence of TVRIncidence of MIRecurrent ISRMyocardial infarctionCause mortalityStent restenosisSystematic reviewIntravascular brachytherapyOutcomes of interestVessel revascularizationCoronary DrugObservational studyMeta-AnalysisIncidencePrevious treatmentBrachytherapyTwo yearsPatientsRestenosisMortalityStentsOutcomesTreatmentLimited studies